The Amyotrophic Lateral Sclerosis (ALS) Treatment market was valued at USD 726.62 Million in 2024 and is expected to reach USD 1,041.27 Million by 2032, growing at a CAGR of 4.6% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.